Reply to Goulden et al.: Risk of Bias in Study of Varenicline and Cardiovascular Outcomes.

Saved in:
Bibliographic Details
Title: Reply to Goulden et al.: Risk of Bias in Study of Varenicline and Cardiovascular Outcomes.
Authors: Gershon AS; 1 Sunnybrook Health Sciences Centre Toronto, Ontario, Canada.; 2 Institute for Clinical Evaluative Sciences Toronto, Ontario, Canada.; 3 University of Toronto Toronto, Ontario, Canada.; 4 The Hospital for Sick Children Toronto, Ontario, Canada., Campitelli MA; 2 Institute for Clinical Evaluative Sciences Toronto, Ontario, Canada., Hawken S; 5 Ottawa Hospital Research Institute Ottawa, Ontario, Canada.; 6 University of Ottawa Ottawa, Ontario, Canada.; 9 Institute for Clinical Evaluative Sciences Ottawa, Ontario, Canada., Sproule BA; 3 University of Toronto Toronto, Ontario, Canada.; 7 Centre for Addiction and Mental Health Toronto, Ontario, Canada., Selby P; 3 University of Toronto Toronto, Ontario, Canada.; 7 Centre for Addiction and Mental Health Toronto, Ontario, Canada.; 8 Ontario Tobacco Research Unit Toronto, Ontario, Canada and.
Source: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2018 Sep 01; Vol. 198 (5), pp. 691-692.
Publication Type: Letter; Comment
Journal Info: Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-4970
DOI:10.1164/rccm.201804-0639LE